CD7-CAR-NK-92 demonstrated selective and potent antitumor activity against T-ALL cell lines and T-ALL xenograft mouse models, which could be mediated by increased granzyme B and IFN-γ secretion [98, 99]. The gene discussed is GZMB; the disease is acute lymphoblastic leukemia.